Fox Chase Cancer Center News

PHILADELPHIA (June 4, 2021)—The likelihood of prostate cancer surgery for patients presenting for treatment across Pennsylvania declined among Black patients, but not white patients, during the initial wave of the COVID-19 pandemic, according to new research from Fox Chase Cancer Center.

PHILADELPHIA (June 3, 2021)—Researchers from Fox Chase Cancer Center have presented new data showing that oncologists feel underprepared to communicate the results of tumor genetic profiling (TGP) to their patients, particularly to African American patients who have more mistrust around healthcare and particularly around genetic information and testing.

PHILADELPHIA (June 3, 2021) – In a presentation of real-world data, researchers from Fox Chase Cancer Center have concluded that the choice of first-line platinum chemotherapy did not result in a significant difference in overall survival benefit among patients with advanced bladder cancer who were able to go on to receive second-line immunotherapy.

PHILADELPHIA (May 28, 2021)—Scientists at Fox Chase Cancer Center have provided new insight into how viruses spread through the central nervous system and how they can live on in these parts of the body long after a person appears to have recovered from disease.

PHILADELPHIA (May 28, 2021)—Scientists at Fox Chase Cancer Center have provided new insight into how viruses spread through the central nervous system and how they can live on in these parts of the body long after a person appears to have recovered from disease.

PHILADELPHIA (May 27, 2021)—The Bladder Cancer Advocacy Network (BCAN) has recognized Benjamin Miron, MD, a medical oncology fellow at Fox Chase Cancer Center, with the 2021 New Discoveries Young Investigator Award.

PHILADELPHIA (May 26, 2021)—Although there have been treatment advances over the years, multiple myeloma is still an incurable disease. It is characterized by periods of remission and relapse resulting in decreased survival outcomes following initial therapies. But now, Fox Chase Cancer Center is one of a handful of hospitals in the country to offer patients a new treatment option.

PHILADELPHIA (May 24, 2021)—Mary B. Daly, MD, PhD, FACP, professor in the Department of Clinical Genetics and director of the Risk Assessment Program at Fox Chase Cancer Center, recently received the National Comprehensive Cancer Network’s (NCCN) Rodger Winn Award.